Maria Ferreira
Assistente de Investigação / Research Assistant
Maria Ferreira é técnica de investigação no Grupo de Investigação Cardiovascular de Mafalda Bourbon, no Instituto Nacional de Saúde Doutor Ricardo Jorge, onde colabora nos estudos Dislipidemias Familiares (DFs) e Genómica Funcional em Dislipidemias Familiares (FunGen). Atualmente, trabalha no projeto FH-EARLY, financiado pela União Europeia, que se foca no diagnóstico precoce e no tratamento personalizado de doentes com Hipercolesterolemia Familiar. Colabora também no projeto PerMedFH (Personalização do diagnóstico e tratamento da Hipercolesterolemia Familiar).
É mestre em Biologia Humana e Ambiente e licenciada em Bioquímica, ambos pela Faculdade de Ciências da Universidade de Lisboa. No âmbito do seu mestrado, desenvolveu entre 2021 e 2023 a dissertação intitulada “Espectro de variantes APOB e caracterização funcional em doentes portugueses com fenótipo de Hipercolesterolemia Familiar”.
Desde 2021 integra a equipa laboratorial de Mafalda Bourbon. É também membro Familial Hypercholesterolaemia Variant Curation Expert Panel (FH VCEP) do Clinical Genome Resource, onde trabalha como curadora júnior, e do Centro Cardiovascular da Universidade de Lisboa (CCUL), no grupo de Medicina Molecular em Dislipidemia e Diabetes.
---
É mestre em Biologia Humana e Ambiente e licenciada em Bioquímica, ambos pela Faculdade de Ciências da Universidade de Lisboa. No âmbito do seu mestrado, desenvolveu entre 2021 e 2023 a dissertação intitulada “Espectro de variantes APOB e caracterização funcional em doentes portugueses com fenótipo de Hipercolesterolemia Familiar”.
Desde 2021 integra a equipa laboratorial de Mafalda Bourbon. É também membro Familial Hypercholesterolaemia Variant Curation Expert Panel (FH VCEP) do Clinical Genome Resource, onde trabalha como curadora júnior, e do Centro Cardiovascular da Universidade de Lisboa (CCUL), no grupo de Medicina Molecular em Dislipidemia e Diabetes.
---
Maria Ferreira is a research technician in Mafalda Bourbon’s Cardiovascular Research Group at the National Health Institute Doutor Ricardo Jorge, where she collaborates in the Familial Dyslipidaemias (DFs) and Functional Genomics in Familial Dyslipidaemias (FunGen) studies. She is currently working on the FH-EARLY project, funded by the European Union, which focuses on early diagnosis and personalized care for patients with Familial Hypercholesterolaemia. She also collaborates in the PerMedFH project (Personalizing diagnosis and treatment for Familial Hypercholesterolemia).
She holds an MSc in Human Biology and Environment and a BSc in Biochemistry, both from the Faculty of Sciences of the University of Lisbon. As part of her MSc, Maria developed her thesis project in 2021–2023, entitled “APOB Variants Spectrum and Functional Characterization in Portuguese Patients with Familial Hypercholesterolaemia Phenotype”.
Since 2021, she has been a member of Mafalda Bourbon’s laboratory team. In addition, she is a member of the Familial Hypercholesterolaemia Variant Curation Expert Panel (FH VCEP) at the Clinical Genome Resource, where she works as a junior curator, and a member of the Cardiovascular Centre of the University of Lisbon (CCUL), Molecular Medicine in Dyslipidaemia and Diabetes Research Group.
She holds an MSc in Human Biology and Environment and a BSc in Biochemistry, both from the Faculty of Sciences of the University of Lisbon. As part of her MSc, Maria developed her thesis project in 2021–2023, entitled “APOB Variants Spectrum and Functional Characterization in Portuguese Patients with Familial Hypercholesterolaemia Phenotype”.
Since 2021, she has been a member of Mafalda Bourbon’s laboratory team. In addition, she is a member of the Familial Hypercholesterolaemia Variant Curation Expert Panel (FH VCEP) at the Clinical Genome Resource, where she works as a junior curator, and a member of the Cardiovascular Centre of the University of Lisbon (CCUL), Molecular Medicine in Dyslipidaemia and Diabetes Research Group.